— Know what they know.
Not Investment Advice

ACAD NASDAQ

ACADIA Pharmaceuticals Inc.
1W: -3.5% 1M: -4.1% 3M: -11.1% YTD: -18.9% 1Y: -1.7% 3Y: -2.6% 5Y: -2.1%
$21.10
-0.22 (-1.03%)
 
Weekly Expected Move ±4.8%
$19 $20 $21 $22 $23
NASDAQ · Healthcare · Biotechnology · Alpha Radar Sell · Power 37 · $3.6B mcap · 169M float · 1.13% daily turnover · Short 44% of daily vol

📊 Key Metrics

TTM
$1B
Revenue
+9.9% YoY
$376M
Net Income
+64.1% YoY
$212M
Free Cash Flow
+328.3% YoY
90.8%
Gross Margin
-1.7%
Op. Margin
1.4%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE38.3%
ROA27.3%
ROIC57.4%

Valuation

P/E9.6
P/B2.9
EV/EBITDA29.4

Leverage

Debt/Equity0.04
Current Ratio3.83
Interest Cov.0.0x

Quality Scores

Piotroski F5/9
Altman Z6.74
Beneish M-1.04

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms